
OPTH
Healthcare · Drug Manufacturers - Specialty & Generic · $12.9M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now
Beat estimates in 0 of the last 3 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 13, 2026 | Time not confirmed | -0.29 | — | — |
| Aug 14, 2026 | Time not confirmed | -0.26 | -0.40 | -53.8% |
| Jun 2, 2026 | Time not confirmed | — | -0.36 | — |
| Feb 25, 2026 | Time not confirmed | — | -0.35 | — |
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional…